Test Price
2,800 AED✅ Home Collection Available
NLGN4X Gene Autism Susceptibility, X‑linked Type 2 Genetic Test in UAE | 2800 AED | DHA Guidelines
Executive Summary & Core Metrics
This genetic test detects pathogenic variants in the NLGN4X gene associated with X‑linked autism spectrum disorder and intellectual disability using Next‑Generation Sequencing (NGS). Achieves 99.9% diagnostic sensitivity with ISO‑accredited processing. Patient‑centric logistics include VIP mobile phlebotomy and temperature‑controlled cold‑chain home collection, available daily 8 AM–11 PM.
Trusted Precision & Patient‑Centric Logistics:
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑Accredited Next‑Generation Sequencing Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection.
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance for result interpretation provided by DHA‑licensed specialists.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The NLGN4X gene test uses Next‑Generation Sequencing (NGS) to detect single nucleotide variants, small indels, and copy number changes responsible for X‑linked autism susceptibility and intellectual disability, delivering a clinically actionable molecular diagnosis.
| Feature | Our Test – NLGN4X NGS Full Gene Sequencing | Closest Alternative – Chromosomal Microarray (CMA) Autism Panel |
|---|---|---|
| Precision | Detects single nucleotide variants, small indels, and copy number changes with >99.9% analytical sensitivity | Only identifies large copy number variants (CNVs); misses point mutations and small indels |
| Methodology | Next‑Generation Sequencing (Illumina platform) with bioinformatic validation | Array‑Comparative Genomic Hybridization (aCGH) |
| Speed | 3 to 4 weeks from sample receipt | Typically 4 to 6 weeks |
Physician Insight & Safety Protocols
“This single‑gene analysis offers critical insights into X‑linked autism susceptibility, but results must be interpreted within the full clinical context. I emphasize that no isolated genetic test replaces comprehensive neurological and developmental assessment. Always discuss findings with your specialist to guide personalized care.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Patient Advisory
Important Medication Guidance
Do not alter or discontinue any prescribed medication solely based on genetic results. Genetic test outcomes are supplementary and require integration with current clinical management by your treating physician.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Pregnant women (unless specifically indicated by a specialist) and individuals unable to provide informed consent for genetic testing under Federal Decree‑Law No. 4 of 2016 on Medical Liability.
- ER Red Flags: If a pathogenic variant is reported and the patient develops new‑onset seizures, sudden neurological regression, or loss of previously acquired developmental milestones, seek immediate medical attention.
Patient FAQ & Clinical Guidance
1. What is the NLGN4X gene test and why is it performed?
This test sequences the entire NLGN4X gene to identify mutations causing X‑linked autism spectrum disorder and intellectual disability, enabling precise diagnosis and genetic counseling.
2. How is the sample collected and what are the pre‑test requirements?
A certified phlebotomist collects a blood sample or a dried blood spot (FTA card) during a VIP home visit. Pre‑test genetic counseling is strongly recommended to map family history.
3. What are the turnaround time, cost, and insurance options?
Your comprehensive report is delivered within 3 to 4 weeks for AED 2800, with direct insurance billing verification available through our dedicated WhatsApp line.
UAE Regulatory & Data Privacy Adherence
- Genetic testing performed in accordance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Informed consent and patient safety obligations adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability.
- Laboratory accredited to ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | NLGN4X Gene Autism Susceptibility, X‑linked Type 2 Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3 to 4 weeks from sample receipt |
| Sample Type / Matrix | Peripheral Blood or Dried Blood Spot (FTA Card) |
| Methodology Used | Next‑Generation Sequencing (NGS) – Illumina Platform |
| ICD‑10‑CM Code | F84.0, Z13.85, Z15.89 |
| LOINC Code | 96393-4 |
| DHA Facility License & Laboratory Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians